RE-186 HYDROXYETHYLIDENE DIPHOSPHONATE [RE-186 HEDP] DOSE-ESCALATION STUDY IN PATIENTS WITH METASTASIZED PROSTATE-CANCER - TARGET ORGAN DOSIMETRY, NARROW TOXICITY AND OPTIMIZED DATA-COLLECTION
Mc. Graham et al., RE-186 HYDROXYETHYLIDENE DIPHOSPHONATE [RE-186 HEDP] DOSE-ESCALATION STUDY IN PATIENTS WITH METASTASIZED PROSTATE-CANCER - TARGET ORGAN DOSIMETRY, NARROW TOXICITY AND OPTIMIZED DATA-COLLECTION, The Journal of nuclear medicine, 35(5), 1994, pp. 160000036-160000037